HEB - short interest is more than insider holdings,...
creates a puzzling hypothesis.
could management be hedging ? or is it an outside (informed) influence
Hemispherx Biopharma Inc $ 2.42
HEB -0.12
Short Interest (Shares Short) 10,269,000
Days To Cover (Short Interest Ratio) 0.5
Short Percent of Float 12.39 %
Short Interest - Prior 7,046,100
Short % Increase / Decrease 45.74 %
Short Squeeze Ranking™ 13
% From 52-Wk High ($ 4.54 ) -78.74 %
% From 52-Wk Low ($ 0.25 ) 90.16 %
% From 200-Day MA ($ 0.89 ) 64.96 %
% From 50-Day MA ($ 2.10 ) 17.32 %
Price % Change (52-Week) 217.50 %
Shares Float 82,860,000
Total Shares Outstanding 84,621,416
% Owned by Insiders 7.82 %
% Owned by Institutions 2.40 %
invest at your own risk, based on your own due diligence, at your own risk tolerance